Gold in the Ivory Tower: Equity Rewards of Outlicensing

Nature Biotechnology, Vol. 24, No. 5, pp. 509-515, May 2006

7 Pages Posted: 25 May 2006

See all articles by Mark Edwards

Mark Edwards

Recombinant Capital

Fiona Murray

Massachusetts Institute of Technology (MIT) - Entrepreneurship Center

Robert Yu

Recombinant Capital

Abstract

An analysis of life-science initial public offerings from three time periods reveals that the equity share received by universities and their academic researchers has changed over time.

Keywords: biotechnology, licensing, equity

JEL Classification: L14, L31, O34

Suggested Citation

Edwards, Mark and Murray, Fiona E. and Yu, Robert, Gold in the Ivory Tower: Equity Rewards of Outlicensing. Nature Biotechnology, Vol. 24, No. 5, pp. 509-515, May 2006, Available at SSRN: https://ssrn.com/abstract=904258

Mark Edwards (Contact Author)

Recombinant Capital ( email )

2033 N. Main St.
Suite 1050
Walnut Creek, CA 94596
United States

Fiona E. Murray

Massachusetts Institute of Technology (MIT) - Entrepreneurship Center ( email )

United States

Robert Yu

Recombinant Capital ( email )

2033 N. Main St.
Suite 1050
Walnut Creek, CA 94596
United States
925-952-3870 (Phone)

HOME PAGE: http://www.recap.com

Here is the Coronavirus
related research on SSRN

Paper statistics

Downloads
65
Abstract Views
512
rank
369,602
PlumX Metrics